These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 28255881)
41. Importance of vial shape and type on the reproducibility of size exclusion chromatography measurement of monoclonal antibodies. Rodriguez-Aller M; Cusumano A; Alain B; Guillarme D; Fekete S J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():131-138. PubMed ID: 27131473 [TBL] [Abstract][Full Text] [Related]
42. Purification of monoclonal antibodies using high performance liquid chromatography (HPLC). Perry GA; Jackson JD; McDonald TL; Crouse DA; Sharp JG Prep Biochem; 1984-1985; 14(5):431-47. PubMed ID: 6336002 [TBL] [Abstract][Full Text] [Related]
43. Biophysical properties of the clinical-stage antibody landscape. Jain T; Sun T; Durand S; Hall A; Houston NR; Nett JH; Sharkey B; Bobrowicz B; Caffry I; Yu Y; Cao Y; Lynaugh H; Brown M; Baruah H; Gray LT; Krauland EM; Xu Y; Vásquez M; Wittrup KD Proc Natl Acad Sci U S A; 2017 Jan; 114(5):944-949. PubMed ID: 28096333 [TBL] [Abstract][Full Text] [Related]
45. Structure-Based Optimization of Antibody-Based Biotherapeutics for Improved Developability: A Practical Guide for Molecular Modelers. Thorsteinson N; Comeau SR; Kumar S Methods Mol Biol; 2023; 2552():219-235. PubMed ID: 36346594 [TBL] [Abstract][Full Text] [Related]
46. The bioanalysis of the monoclonal antibody trastuzumab by high-performance liquid chromatography with fluorescence detection after immuno-affinity purification from human serum. Damen CW; Derissen EJ; Schellens JH; Rosing H; Beijnen JH J Pharm Biomed Anal; 2009 Dec; 50(5):861-6. PubMed ID: 19487098 [TBL] [Abstract][Full Text] [Related]
47. Affinity-based methodologies and ligands for antibody purification: advances and perspectives. Roque AC; Silva CS; Taipa MA J Chromatogr A; 2007 Aug; 1160(1-2):44-55. PubMed ID: 17618635 [TBL] [Abstract][Full Text] [Related]
48. Determination of thiol-to-protein ratio and drug-to-antibody ratio by in-line size exclusion chromatography with post-column reaction. Furuki K; Toyo'oka T Anal Biochem; 2017 Jun; 527():33-44. PubMed ID: 28432000 [TBL] [Abstract][Full Text] [Related]
49. Developability index: a rapid in silico tool for the screening of antibody aggregation propensity. Lauer TM; Agrawal NJ; Chennamsetty N; Egodage K; Helk B; Trout BL J Pharm Sci; 2012 Jan; 101(1):102-15. PubMed ID: 21935950 [TBL] [Abstract][Full Text] [Related]
50. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies. Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y MAbs; 2015; 7(3):553-61. PubMed ID: 25790175 [TBL] [Abstract][Full Text] [Related]
51. Combined Protein A and size exclusion high performance liquid chromatography for the single-step measurement of mAb, aggregates and host cell proteins. Gjoka X; Schofield M; Cvetkovic A; Gantier R J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Dec; 972():48-52. PubMed ID: 25310707 [TBL] [Abstract][Full Text] [Related]
52. Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. Wong C; Strachan-Mills C; Burman S J Chromatogr A; 2012 Dec; 1270():153-61. PubMed ID: 23182937 [TBL] [Abstract][Full Text] [Related]
53. Integrated process for the purification of antibodies combining aqueous two-phase extraction, hydrophobic interaction chromatography and size-exclusion chromatography. Azevedo AM; Rosa PA; Ferreira IF; Aires-Barros MR J Chromatogr A; 2008 Dec; 1213(2):154-61. PubMed ID: 18995863 [TBL] [Abstract][Full Text] [Related]
54. Purification of antibodies using affinity chromatography. Darcy E; Leonard P; Fitzgerald J; Danaher M; O'Kennedy R Methods Mol Biol; 2011; 681():369-82. PubMed ID: 20978976 [TBL] [Abstract][Full Text] [Related]
55. Structural and functional characteristics of virgin and fouled Protein A MabSelect resin cycled in a monoclonal antibody purification process. Zhang S; Xu K; Daniels W; Salm J; Glynn J; Martin J; Gallo C; Godavarti R; Carta G Biotechnol Bioeng; 2016 Feb; 113(2):367-75. PubMed ID: 26175184 [TBL] [Abstract][Full Text] [Related]
56. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods. Li W; Yang B; Zhou D; Xu J; Li W; Suen WC J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491 [TBL] [Abstract][Full Text] [Related]
57. Antibody purification by affinity chromatography based on small molecule affinity ligands identified by SPR-based screening of chemical microarrays. Arnold M; Bittermann H; Kalbfuss-Zimmermann B; Neumann T; Schmidt K; Sekul R; Hilbrig F; Ludolph H; Freitag R J Chromatogr A; 2011 Jul; 1218(29):4649-59. PubMed ID: 21683366 [TBL] [Abstract][Full Text] [Related]
58. Blueprint for antibody biologics developability. Mieczkowski C; Zhang X; Lee D; Nguyen K; Lv W; Wang Y; Zhang Y; Way J; Gries JM MAbs; 2023; 15(1):2185924. PubMed ID: 36880643 [TBL] [Abstract][Full Text] [Related]
59. Rapid single-tube method for small-scale affinity purification of polyclonal antibodies using HaloTag Technology. Hata T; Nakayama M J Biochem Biophys Methods; 2007 Jun; 70(4):679-82. PubMed ID: 17331584 [TBL] [Abstract][Full Text] [Related]
60. Coupled affinity and sizing chromatography: a novel in-process analytical tool to measure titer and trend Fc-protein aggregation. Lemmerer M; London AS; Panicucci A; Gutierrez-Vargas C; Lihon M; Dreier P J Immunol Methods; 2013 Jul; 393(1-2):81-5. PubMed ID: 23612045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]